# Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effectiveness-and-safety-of-rivaroxaban-and-warfarin-for-prevention-of-major/

## Facts

| Field | Value |
| --- | --- |
| Author Names | William L. Baker,Jan Beyer‐Westendorf,Thomas J. Bunz,Daniel Eriksson,Anna‐Katharina Meinecke,Nitesh Sood,Craig I Coleman |
| Citations | 45 |
| DOI | 10.1111/dom.13787 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2945290480 |
| PMID | 31099460 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Daniel Eriksson](https://scholariq.org/researchers/daniel-eriksson/)

## Paper journal

- [Diabetes Obesity and Metabolism](https://scholariq.org/journals/diabetes-obesity-and-metabolism/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Pharmacovigilance and Adverse Drug Reactions](https://scholariq.org/topics/pharmacovigilance-and-adverse-drug-reactions/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.